Qiagen (QGEN) Reports In-Line Q4 EPS, provides outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts QGEN Hot Sheet
Join SI Premium – FREE
Qiagen (NYSE: QGEN) reported Q4 EPS of $0.62, in-line with the analyst estimate of $0.62. Revenue for the quarter came in at $540 million versus the consensus estimate of $528.47 million.
2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CER) and adj. diluted EPS of at least $2.50 CER
For earnings history and earnings-related data on Qiagen (QGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clover Health Investments (CLOV) Tops Q3 EPS by 1c ; Offers Guidance
- Amplitude, Inc. (AMPL) Tops Q3 EPS by 1c ; Offers Guidance
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
